Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection

Journal of Immunology

Volumn 164, Issue 12, 2000, Pages 6426-6434

  Onno, Myriam ^a,c   Pangault, Céline ^a   Le Friec, Gaëlle ^a   Guilloux, Valérie ^a   André, Patrice ^b   Fauchetz, Renée ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Lab Univ d'Hematologie Biol C   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; IMMEDIATE EARLY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNOMODULATION; IMMUNOSTIMULATION; LATENT VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS PNEUMONIA; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0034659769     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.12.6426     Document Type: Article

References (43)

1. de Jong, M. D., G. J. Galasso, B. Gazzard, P. D. Griffiths, D. A. Jabs, E. R. Kern, and S. A. Spector. 1998. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res. 39:141.
2. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248.
3. Ahn, K., A. Angulo, P. Ghazal, P. A. Peterson, Y. Yang, and K. Fruh. 1996. Human cytomegalovirus inhibits antigen presentation by a sequential multislep process. Proc. Natl. Acad. Sci. USA 93:10990.
4. Chapman, T. L., A P. Heikeman, and P. J. Bjorkman. 1999. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11:603.
5. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. J. McMichael, and G. W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031.
6. Le Bouteiller, P. 1997. HLA-G: on the track of immunological functions. Eur. J. Immunogenet. 24:397.
7. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273.
8. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:3096.
9. Cantoni, C., S. Verdiani, M. Falco, A. Pessino, M. Cilli, R. Conte, D. Pende, M. Ponte, M. S. Mikaelsson, L. Moretta, et al. 1998. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur. S. Immunol. 28:1980.
10. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189:1093.
11. Allan, D. S., M. Colonna, L. L. Lanier, T. D. Churakova, J. S. Abrams, S. A. Ellis, A. J. McMichael, and V. M. Braud. 1999. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189:1149.
12. Samaridis. J., and M. Colonna. 1997. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27:660.
13. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809.
14. Le Gal, F. A., B. Riteau, C. Sedlik, I. Khalil-Daher, C. Menier, J. Dausset, J. G. Guillet, E. D. Carosella, and N. Rouas-Freiss. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11:1351.
15. Rouas-Freiss, N., I. Khalil-Daher, B. Riteau, C. Menier, P. Paul, J. Dausset, and E. D. Carosella. 1999. The immunotolerance role of HLA-G. Semin. Cancer Biol. 9:3.
16. Carosella, E. D., N. Rouas-Freiss, P. Paul, and J. Dausset. 1999. HLA-G, a tolerance molecule from the major histocompatibility complex. Immunol. Today 20:60.
17. Mitsuishi, Y., K. Miyazawa, A. Sonoda, and P. I. Terasaki. 1997. Cellular function of soluble HLA-G. In Proceedings of the Twelfth International Histocompatibility Workshop and Conference, Vol. 2. D. Charron, ed. EDK, Paris, France, p. 251.
18. Pangault, C., L. Amiot, S. Caulet-Maugendre, F. Brasseur, F. Burtin, V. Guilloux, B. Drenou, R. Fauchet, and M. Onno. 1999. HLA-G protein expression is not induced during malignant transformation. Tissue Antigens 53:335.
19. Amiot, L., M. Onno, B. Drenou, C. Monvoisin, and R. Fauchet. 1998. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum. Immunol. 59:524.
20. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059.
21. Bolovan-Fritts, C. A., E. S. Mocarski, and J. A. Wiedeman. 1999. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93:394.
22. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597.
23. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119.
24. Sinzger, C., B. Plachter, A. Grefte, T. H. The, and G. Jahn. 1996. Tissue macrophages are infected by human cytomegalovirus in vivo. J. Infect. Dis. 173:240.
25. Lafemina, R. L., M. C. Pizzorno, J. D. Mosca, and G. S. Hayward. 1989. Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes. Virology 172:584.
26. Pizzorno, M. C., P. O'Hare, L. Sha, R. L. LaFemina, and G. S. Hayward. 1988. Trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus. J. Virol. 62:1167.
27. Wieland, S., U. Dobbeling, and S. Rusconi. 1991. Interference and synergism of glucocorticoid receptor and octamer factors. EMBO J. 10:2513.
28. Gerna, G., M. G. Revello, E. Percivalle, M. Zavattoni, M. Parea, and M. Battaglia. 1990. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J. Clin. Microbiol. 28:2681.
29. Lee, N., A. R. Malacko, A. Ishitani, M. C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591.
30. Kirszenbaum, M., P. Moreau, E. Gluckman, J. Dausset, and E. Carosella. 1994. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. USA 91:4209.
31. Larsson, S., C. Soderberg-Naucler, F. Z. Wang, and E. Moller. 1998. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 38:271.
32. Maier, S., D. E. Geraghty, and E. H. Weiss. 1999. Expression and regulation of HLA-G in human glioma cell lines. Transplant. Proc. 31:1849.
33. Masucci, M. G., and I. Ernberg. 1994. Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol. 2:125.
34. Rebmann, V., K. Pfeiffer, M. Passler, S. Ferrone, S. Maier, E. Weiss, and H. Grosse-Wilde. 1999. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53:14.
35. Guillaudeux, T., A. M. Rodriguez, M. Girr, V. Mallet, S. A. Ellis, L. L. Sargent, R. Fauchet, E. Alsat, and P. LeBouteiller. 1995. Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J. Immunol. 154: 3283.
36. Chu, W., J. Gao, W. J. Murphy, and J. S. Hunt. 1999. A candidate interferon-γ activated site (GAS element) in the HLA-G promoter does not bind nuclear proteins. Hum. Immunol. 60:1113.
37. Mocarski, E. S. 1996. Cytomegalovirus and their replication. In Fields Virology, Vol. 2. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 2447.
38. Schust. D. J., D. Tortorella, J. Seebach, C. Phan, and H. L. Ploegh. 1998. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188:497.
39. Fish, K. N., W. Britt, and J. A. Nelson. 1996. A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70:1855.
40. Krause, H., H. Hebart, G. Jahn, C. A. Muller, and H. Einsele. 1997. Screening for CMV-specinc T cell proliferation to identify patients at risk of developing late onset CMV disease Bone Marrow Transplant. 19:1111.
41. Ljungman, P., J. Aschan, J. N. Azinge, L. Brandt, A. Ehrnst, V. Hammarstrom, S. Klaesson, A. Linde, B. Lonnqvist, O. Ringden, et al. 1993. Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation. Br. J. Haematol. 83:118.
42. Carney, W. P., and M. S. Hirsch. 1981. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J. Infect. Dis. 144:47.
43. Rinaldo, C. R., Jr., P. H. Black, and M. S. Hirsch. 1977. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J. Infect. Dis. 136:667.